Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, Ozempic
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify on Capitol Hill Tuesday.
Novo Nordisk CEO grilled by Congress over Ozempic, Wegovy prices in US
For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their health.
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.
LIVE
10h
Ozempic and Wegovy drugmaker treating US as its 'cash cow', Sanders says
Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...
4h
Ozempic can improve a common, chronic skin condition, new study claims
Hidradenitis suppurativa is a lesion-causing inflammatory disorder that affects at least 1 in 100 people and is strongly ...
1d
Ozempic and Wegovy Sales Will Soon Pay for $68 Billion of Novo R&D
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...
NBC Los Angeles
4d
Do GLP-1 supplements work? What to know about ‘nature's Ozempic'
Here's what doctors think about them. Weight loss with
Ozempic
or
Wegovy
can be effective, but expensive. Enter so-called ...
4d
Children as Young as 10 Are Taking Ozempic-Like Drugs, Doctors Warn of Unknown ‘Long-Term Consequences’
Doctors are sending out a warning after children as young as 10 years old are using drugs like Ozempic and Wegovy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novo Nordisk
United States Senate
Bernie Sanders
GLP-1
Lars Fruergaard Jørgensen
Feedback